{"id":"W2979492980","doi":"10.14309/01.ajg.0000592088.78600.39","title":"638 Clinical Effectiveness of First-Line Anti-TNF Therapies and Second-Line Anti-TNF Therapy Post-Vedolizumab Discontinuation in Patients With Ulcerative Colitis or Crohn's Disease","year":2019,"lang":"en","type":"article","venue":"The American Journal of Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Takeda (Canada); University of British Columbia","funders":"","keywords":"Certolizumab pegol; Vedolizumab; Adalimumab; Medicine; Golimumab; Infliximab; Ulcerative colitis; Internal medicine; Discontinuation; Inflammatory bowel disease; Gastroenterology; Crohn's disease; Tumor necrosis factor alpha; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002035345,0.0001507616,0.0006355797,0.0006246018,0.0002332301,0.0007989898,0.0003251936,0.0003305127,0.001413169],"category_scores_gemma":[0.005579388,0.0001455063,0.000805337,0.001064381,0.0002395694,0.0004441064,0.0003451737,0.0004619999,0.0002358114],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004496499,"about_ca_system_score_gemma":0.000308498,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000961255,"about_ca_topic_score_gemma":0.00107151,"domain_scores_codex":[0.9981463,0.0007631143,0.000345616,0.0003034216,0.0003044396,0.0001370624],"domain_scores_gemma":[0.9908282,0.002004183,0.006213392,0.0001988438,0.0003362197,0.0004191091],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008078579,0.0000478181,0.9958378,0.00008481309,0.0002112457,0.00004085222,0.00003270584,0.00005575519,0.00006612732,0.00000811801,0.00008432475,0.002722473],"study_design_scores_gemma":[0.00005255459,0.0005590513,0.9982588,0.00004908278,0.0001285395,0.0003089594,0.00006428471,0.0001338381,0.00006363679,0.00001072729,0.000366376,0.000004082194],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9953918,0.00291458,0.00006767278,0.00006610369,0.00001116215,0.0000168546,0.000981565,0.000003219418,0.000547045],"genre_scores_gemma":[0.9986705,0.0003656897,0.00009658631,0.00004317927,0.00002196151,0.0000202137,0.0006980191,0.000001612302,0.00008221781],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002035345,"threshold_uncertainty_score":0.01076406,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006435695903370625,"score_gpt":0.2560078063583899,"score_spread":0.2495721104550193,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}